Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 20.55
-0.95 (-4.42%)
Aug 4, 2026, 1:23 PM CST
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.06 billion as of August 4, 2026. Its market cap has decreased by -26.87% in one year.
Market Cap
1.06B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.55
ChartMarket Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.06B, an increase of 49.53%. That is a compound annual growth rate of 8.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.06B | -8.12% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | 711.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.27B |
| Enimmune | 1.20B |
| BiOptic | 1.12B |
| LabTurbo Biotech | 1.10B |
| U-Neuron Biomedical | 1.08B |
| Level Biotechnology | 1.03B |
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |